185 related articles for article (PubMed ID: 22960427)
21. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.
Di Martino V; Rufat P; Boyer N; Renard P; Degos F; Martinot-Peignoux M; Matheron S; Le Moing V; Vachon F; Degott C; Valla D; Marcellin P
Hepatology; 2001 Dec; 34(6):1193-9. PubMed ID: 11732009
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of hepatitis C virus infection after liver transplantation.
Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
[TBL] [Abstract][Full Text] [Related]
23. Late liver-related mortality from complications of transfusion-acquired hepatitis C.
Kamitsukasa H; Harada H; Tanaka H; Yagura M; Tokita H; Ohbayashi A
Hepatology; 2005 Apr; 41(4):819-25. PubMed ID: 15793849
[TBL] [Abstract][Full Text] [Related]
24. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
27. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
[TBL] [Abstract][Full Text] [Related]
28. Risk and predictors of mortality associated with chronic hepatitis B infection.
Iloeje UH; Yang HI; Jen CL; Su J; Wang LY; You SL; Chen CJ;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):921-31. PubMed ID: 17678844
[TBL] [Abstract][Full Text] [Related]
29. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
[TBL] [Abstract][Full Text] [Related]
30. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
[TBL] [Abstract][Full Text] [Related]
31. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
32. Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; Wang CH; Chen WJ; Chen CJ;
J Infect Dis; 2012 Aug; 206(4):469-77. PubMed ID: 22811301
[TBL] [Abstract][Full Text] [Related]
33. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
McMahon BJ; Bruden D; Bruce MG; Livingston S; Christensen C; Homan C; Hennessy TW; Williams J; Sullivan D; Rosen HR; Gretch D
Gastroenterology; 2010 Mar; 138(3):922-31.e1. PubMed ID: 19909749
[TBL] [Abstract][Full Text] [Related]
34. Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway.
Kristiansen MG; Løchen ML; Gutteberg TJ; Mortensen L; Eriksen BO; Florholmen J
J Viral Hepat; 2011 Apr; 18(4):237-44. PubMed ID: 20337923
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users.
Basu D; Kumar V; Sharma AK; Barnwal PK; Mattoo SK
Asian J Psychiatr; 2013 Feb; 6(1):52-5. PubMed ID: 23380318
[TBL] [Abstract][Full Text] [Related]
37. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
38. Natural history of chronic hepatitis C.
Pagliaro L; Peri V; Linea C; Cammà C; Giunta M; Magrin S
Ital J Gastroenterol Hepatol; 1999; 31(1):28-44. PubMed ID: 10091101
[TBL] [Abstract][Full Text] [Related]
39. The outcome of heart transplantation in hepatitis C-positive recipients.
Lin MH; Chou NK; Chi NH; Chen YS; Yu HY; Huang SC; Ko WJ; Chou HW; Wang SS
Transplant Proc; 2012 May; 44(4):890-3. PubMed ID: 22564576
[TBL] [Abstract][Full Text] [Related]
40. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
Shindo M; Ken A; Okuno T
Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]